Novel strain of the genus lactobacillus and topical pharmaceutical formulations containing it
AssigneeSINCLAIR PHARMA s.r.l.
InventorMarco MASTRODONATO
Life of this patent
Estimating the term…
Abstract
This invention relates to a novel strain of lactobacillus, called Lactobacillus acidophilus EUVAG, and topical vaginal pharmaceutical formulations containing it, for use in all forms of dysbiosis and variations in vaginal pH which can cause recurrent bacterial or fungal vaginal infections.
Claims7
Lactobacillus acidophilus EUVAG strain deposited in the DSMZ collection under the number 19290 on 19 Apr. 2007.
Use of the Lactobacillus acidophilus EUVAG strain for the preparation of medicaments useful for the treatment or prophylaxis of forms of dysbiosis and variations in vaginal pH which can cause recurrent bacterial or fungal vaginal infections.
Dependencies are inferred from the claim text.